RAFAEL HOLDINGS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
RAFAEL HOLDINGS, INC. (RFL) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest of $1.33 million for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2026-04-30 was $1.33M, a 82.28% increase year-over-year.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2026-01-31 was $88.00K.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2025-10-31 was $17.00K.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2025-07-31 was $37.00K.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2025 was -$128.00K.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2024 was -$30.59M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2023 was -$336.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-04-30 | $1.33M 10-Q · filed 2026-06-11 | $1.42M derived: sum of 2 quarters · filed 2026-06-11 | $1.43M 10-Q · filed 2026-06-11 | $1.47M derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | $88.00K 10-Q · filed 2026-03-16 | $105.00K 10-Q · filed 2026-03-16 | $142.00K derived: sum of 3 quarters · filed 2026-03-16 | $870.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | $17.00K 10-Q · filed 2025-12-12 | $54.00K derived: sum of 2 quarters · filed 2025-12-12 | $782.00K derived: sum of 3 quarters · filed 2026-06-11 | $94.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-07-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $765.00K derived: sum of 2 quarters · filed 2026-06-11 | $77.00K derived: sum of 3 quarters · filed 2026-06-11 | -$128.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $728.00K 10-Q · filed 2026-06-11 | $40.00K derived: sum of 2 quarters · filed 2026-06-11 | -$165.00K 10-Q · filed 2026-06-11 | -$554.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | -$688.00K 10-Q · filed 2026-03-16 | -$893.00K 10-Q · filed 2026-03-16 | -$1.28M derived: sum of 3 quarters · filed 2026-03-16 | -$31.22M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | -$205.00K 10-Q · filed 2025-12-12 | -$594.00K derived: sum of 2 quarters · filed 2025-12-12 | -$30.54M derived: sum of 3 quarters · filed 2025-12-12 | -$30.68M derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | -$389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$30.33M derived: sum of 2 quarters · filed 2025-10-29 | -$30.48M derived: sum of 3 quarters · filed 2025-10-29 | -$30.59M 10-K · filed 2025-10-29 |
| 2024-04-30 | -$29.94M 10-Q · filed 2025-06-11 | -$30.09M derived: sum of 2 quarters · filed 2025-06-11 | -$30.21M 10-Q · filed 2025-06-11 | -$30.23M derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-01-31 | -$145.00K 10-Q · filed 2025-03-14 | -$264.00K 10-Q · filed 2025-03-14 | -$292.00K derived: sum of 3 quarters · filed 2025-03-14 | -$345.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-10-31 | -$119.00K 10-Q · filed 2024-12-11 | -$147.00K derived: sum of 2 quarters · filed 2024-12-20 | -$200.00K derived: sum of 3 quarters · filed 2024-12-20 | -$356.00K derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-07-31 | -$28.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$81.00K derived: sum of 2 quarters · filed 2024-12-20 | -$237.00K derived: sum of 3 quarters · filed 2024-12-20 | -$336.00K 10-K/A · filed 2024-12-20 |
| 2023-04-30 | -$53.00K 10-Q · filed 2024-06-14 | -$209.00K derived: sum of 2 quarters · filed 2024-06-14 | -$308.00K 10-Q · filed 2024-06-14 | |
| 2023-01-31 | -$156.00K 10-Q · filed 2024-03-14 | -$255.00K 10-Q · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |